awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47804413-A1C90D00-D529-41B9-BF13-7C737C199421
Q47804413-A1C90D00-D529-41B9-BF13-7C737C199421
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47804413-A1C90D00-D529-41B9-BF13-7C737C199421
The mTOR kinase inhibitor everolimus synergistically enhances the anti-tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS-123 on Mantle cell lymphoma.
P2860
Q47804413-A1C90D00-D529-41B9-BF13-7C737C199421
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47804413-A1C90D00-D529-41B9-BF13-7C737C199421
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e6691f4320dbf61fac273b4a709bd13804d8d88f
P2860
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.